Mangalam Organics to consider FY26 results on May 29
Mangalam Organics Limited will hold a board meeting on May 29, 2026, to approve audited financial results for the quarter and fiscal year ended March 31, 2026. The trading window for designated persons remains closed until 48 hours post-results declaration.

*this image is generated using AI for illustrative purposes only.
Mangalam Organics Limited has announced that its board meeting will be held on Friday, May 29, 2026. The meeting has been convened in accordance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Agenda for the Meeting
The board will primarily focus on the company's financial performance for the recent period. The key item on the agenda is the consideration and approval of the audited standalone and consolidated financial statements. These statements pertain to the quarter and financial year ended March 31, 2026.
Additionally, the board will consider any other business that may be brought before the meeting with the permission of the Chair.
Trading Window Closure
In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct, the trading window for designated persons and their immediate relatives has been closed since April 1, 2026. This restriction will continue to remain in effect until the expiry of 48 hours from the declaration of the audited financial results for the quarter and financial year ended March 31, 2026.
The intimation was addressed to BSE Limited and The National Stock Exchange of India Limited on May 25, 2026, by Charmi Kirtibhai Shah, Company Secretary & Compliance Officer.
Historical Stock Returns for Mangalam Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.46% | +1.61% | +26.10% | +22.78% | -2.32% | -37.70% |
How might Mangalam Organics' FY2026 revenue and profit margins compare to the previous fiscal year, given the volatility in camphor and terpene derivative markets?
Will the board consider announcing a dividend or any capital allocation strategy alongside the FY2026 financial results on May 29?
How could any significant deviation in Mangalam Organics' FY2026 earnings from analyst expectations impact its stock price once the trading window reopens?


































